# Weave Communications, Inc.: financial statements, quarterly

WEAV · NYSE · CIK 1609151 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/weav.md) · [Financials](/companies/weav/financials.md) · [Filings](/companies/weav/filings.md) · [Insiders](/companies/weav/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/weav/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [43.5](/filings/0001609151-24-000149.md) | [45.7 d](/filings/0001609151-24-000021.md) | [47.2](/filings/0001609151-25-000058.md) | [50.6](/filings/0001609151-25-000108.md) | [52.4](/filings/0001609151-25-000135.md) | [54.2 d](/filings/0001609151-26-000016.md) | [55.8](/filings/0001609151-26-000049.md) | [58.5](/filings/0001609151-26-000074.md) | [61.3](/filings/0001609151-25-000135.md) | [63.4 d](/filings/0001609151-26-000016.md) | [65.5](/filings/0001609151-26-000049.md) | [67.5](/filings/0001609151-26-000074.md) |
| Cost of revenue | $m | [13.6](/filings/0001609151-24-000149.md) | [14.1 d](/filings/0001609151-26-000016.md) | [14.2](/filings/0001609151-25-000058.md) | [14.5](/filings/0001609151-25-000108.md) | [14.7](/filings/0001609151-25-000135.md) | [15.1 d](/filings/0001609151-26-000016.md) | [15.9](/filings/0001609151-26-000049.md) | [16.5](/filings/0001609151-26-000074.md) | [17.0](/filings/0001609151-25-000135.md) | [17.3 d](/filings/0001609151-26-000016.md) | [18.0](/filings/0001609151-26-000049.md) | [18.9](/filings/0001609151-26-000074.md) |
| Gross profit | $m | [29.9](/filings/0001609151-24-000149.md) | [31.6 d](/filings/0001609151-26-000016.md) | [33.0](/filings/0001609151-25-000058.md) | [36.1](/filings/0001609151-25-000108.md) | [37.7](/filings/0001609151-25-000135.md) | [39.0 d](/filings/0001609151-26-000016.md) | [39.9](/filings/0001609151-26-000049.md) | [42.0](/filings/0001609151-26-000074.md) | [44.3](/filings/0001609151-25-000135.md) | [46.1 d](/filings/0001609151-26-000016.md) | [47.5](/filings/0001609151-26-000049.md) | [48.7](/filings/0001609151-26-000074.md) |
| Research and development | $m | [8.6](/filings/0001609151-24-000149.md) | [9.1 d](/filings/0001609151-26-000016.md) | [9.6](/filings/0001609151-25-000058.md) | [10.0](/filings/0001609151-25-000108.md) | [9.9](/filings/0001609151-25-000135.md) | [10.8 d](/filings/0001609151-26-000016.md) | [11.2](/filings/0001609151-26-000049.md) | [12.0](/filings/0001609151-26-000074.md) | [13.1](/filings/0001609151-25-000135.md) | [8.2 d](/filings/0001609151-26-000016.md) | [10.8](/filings/0001609151-26-000049.md) | [12.1](/filings/0001609151-26-000074.md) |
| Operating income | $m | [(8.0)](/filings/0001609151-24-000149.md) | [(8.0) d](/filings/0001609151-26-000016.md) | [(8.2)](/filings/0001609151-25-000058.md) | [(9.3)](/filings/0001609151-25-000108.md) | [(6.6)](/filings/0001609151-25-000135.md) | [(7.4) d](/filings/0001609151-26-000016.md) | [(9.3)](/filings/0001609151-26-000049.md) | [(10.2)](/filings/0001609151-26-000074.md) | [(8.9)](/filings/0001609151-25-000135.md) | [(2.2) d](/filings/0001609151-26-000016.md) | [(6.0)](/filings/0001609151-26-000049.md) | [(4.4)](/filings/0001609151-26-000074.md) |
| Interest expense | $m | [0.5](/filings/0001609151-24-000149.md) | [0.4 d](/filings/0001609151-25-000022.md) | [0.3](/filings/0001609151-24-000050.md) | [0.4](/filings/0001609151-24-000093.md) | [0.4](/filings/0001609151-24-000149.md) | [0.4 d](/filings/0001609151-25-000022.md) | [0.4](/filings/0001609151-26-000049.md) | [0.5](/filings/0001609151-26-000074.md) | [0.4](/filings/0001609151-25-000135.md) | [0.4 d](/filings/0001609151-26-000016.md) | [0.4](/filings/0001609151-26-000049.md) | [0.4](/filings/0001609151-26-000074.md) |
| Income tax | $m | [0.1](/filings/0001609151-24-000149.md) | [0.1 d](/filings/0001609151-26-000016.md) | [0.0](/filings/0001609151-25-000058.md) | [0.1](/filings/0001609151-25-000108.md) | [0.1](/filings/0001609151-25-000135.md) | [0.1 d](/filings/0001609151-26-000016.md) | [0.1](/filings/0001609151-26-000049.md) | [(1.1)](/filings/0001609151-26-000074.md) | [0.1](/filings/0001609151-25-000135.md) | [0.0 d](/filings/0001609151-26-000016.md) | [0.1](/filings/0001609151-26-000049.md) | [0.1](/filings/0001609151-26-000074.md) |
| Net income | $m | [(7.1)](/filings/0001609151-24-000149.md) | [(7.0) d](/filings/0001609151-26-000016.md) | [(7.2)](/filings/0001609151-25-000058.md) | [(8.6)](/filings/0001609151-25-000108.md) | [(5.9)](/filings/0001609151-25-000135.md) | [(6.7) d](/filings/0001609151-26-000016.md) | [(8.8)](/filings/0001609151-26-000049.md) | [(8.7)](/filings/0001609151-26-000074.md) | [(8.7)](/filings/0001609151-25-000135.md) | [(1.8) d](/filings/0001609151-26-000016.md) | [(5.8)](/filings/0001609151-26-000049.md) | [(4.3)](/filings/0001609151-26-000074.md) |
| Diluted EPS | $ per share | [(0.10)](/filings/0001609151-24-000149.md) | not reported | [(0.10)](/filings/0001609151-25-000058.md) | [(0.12)](/filings/0001609151-25-000108.md) | [(0.08)](/filings/0001609151-25-000135.md) | not reported | [(0.12)](/filings/0001609151-26-000049.md) | [(0.11)](/filings/0001609151-26-000074.md) | [(0.11)](/filings/0001609151-25-000135.md) | not reported | [(0.07)](/filings/0001609151-26-000049.md) | [(0.05)](/filings/0001609151-26-000074.md) |
| Basic EPS | $ per share | [(0.10)](/filings/0001609151-24-000149.md) | not reported | [(0.10)](/filings/0001609151-25-000058.md) | [(0.12)](/filings/0001609151-25-000108.md) | [(0.08)](/filings/0001609151-25-000135.md) | not reported | [(0.12)](/filings/0001609151-26-000049.md) | [(0.11)](/filings/0001609151-26-000074.md) | [(0.11)](/filings/0001609151-25-000135.md) | not reported | [(0.07)](/filings/0001609151-26-000049.md) | [(0.05)](/filings/0001609151-26-000074.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [63.3](/filings/0001609151-23-000031.md) | [50.8](/filings/0001609151-25-000022.md) | [30.6](/filings/0001609151-24-000050.md) | [51.7](/filings/0001609151-24-000093.md) | [51.1](/filings/0001609151-24-000149.md) | [51.6](/filings/0001609151-26-000016.md) | [53.4](/filings/0001609151-25-000058.md) | [44.7](/filings/0001609151-25-000108.md) | [64.4](/filings/0001609151-25-000135.md) | [55.0](/filings/0001609151-26-000074.md) | [42.2](/filings/0001609151-26-000049.md) | [47.6](/filings/0001609151-26-000074.md) |
| Current assets | $m | [138](/filings/0001609151-23-000031.md) | [130](/filings/0001609151-25-000022.md) | [120](/filings/0001609151-24-000050.md) | [121](/filings/0001609151-24-000093.md) | [123](/filings/0001609151-24-000149.md) | [121](/filings/0001609151-26-000016.md) | [120](/filings/0001609151-25-000058.md) | [99.4](/filings/0001609151-25-000108.md) | [103](/filings/0001609151-25-000135.md) | [105](/filings/0001609151-26-000074.md) | [101](/filings/0001609151-26-000049.md) | [105](/filings/0001609151-26-000074.md) |
| Total assets | $m | [211](/filings/0001609151-23-000031.md) | [201](/filings/0001609151-25-000022.md) | [190](/filings/0001609151-24-000050.md) | [191](/filings/0001609151-24-000093.md) | [192](/filings/0001609151-24-000149.md) | [189](/filings/0001609151-26-000016.md) | [188](/filings/0001609151-25-000058.md) | [204](/filings/0001609151-25-000108.md) | [206](/filings/0001609151-25-000135.md) | [208](/filings/0001609151-26-000074.md) | [204](/filings/0001609151-26-000049.md) | [209](/filings/0001609151-26-000074.md) |
| Current liabilities | $m | [69.9](/filings/0001609151-23-000031.md) | [72.9](/filings/0001609151-25-000022.md) | [68.4](/filings/0001609151-24-000050.md) | [74.1](/filings/0001609151-24-000093.md) | [76.9](/filings/0001609151-24-000149.md) | [76.6](/filings/0001609151-26-000016.md) | [75.2](/filings/0001609151-25-000058.md) | [81.3](/filings/0001609151-25-000108.md) | [82.9](/filings/0001609151-25-000135.md) | [84.6](/filings/0001609151-26-000074.md) | [81.1](/filings/0001609151-26-000049.md) | [84.0](/filings/0001609151-26-000074.md) |
| Total liabilities | $m | [130](/filings/0001609151-23-000031.md) | [122](/filings/0001609151-25-000022.md) | [117](/filings/0001609151-24-000050.md) | [121](/filings/0001609151-24-000093.md) | [123](/filings/0001609151-24-000149.md) | [122](/filings/0001609151-26-000016.md) | [120](/filings/0001609151-25-000058.md) | [125](/filings/0001609151-25-000108.md) | [128](/filings/0001609151-25-000135.md) | [126](/filings/0001609151-26-000074.md) | [121](/filings/0001609151-26-000049.md) | [124](/filings/0001609151-26-000074.md) |
| Long-term debt | $m | [10.0](/filings/0001609151-23-000031.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [0.0](/filings/0001609151-23-000031.md) | [0.0](/filings/0001609151-24-000021.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [80.9](/filings/0001609151-24-000149.md) | [79.0](/filings/0001609151-26-000016.md) | [73.4](/filings/0001609151-25-000108.md) | [69.8](/filings/0001609151-25-000135.md) | [68.8](/filings/0001609151-25-000135.md) | [67.0](/filings/0001609151-26-000074.md) | [68.6](/filings/0001609151-26-000074.md) | [78.9](/filings/0001609151-26-000074.md) | [78.6](/filings/0001609151-25-000135.md) | [82.4](/filings/0001609151-26-000074.md) | [83.3](/filings/0001609151-26-000074.md) | [85.0](/filings/0001609151-26-000074.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3.3 d](/filings/0001609151-24-000149.md) | [3.7 d](/filings/0001609151-26-000016.md) | [(19.7)](/filings/0001609151-25-000058.md) | [22.7 d](/filings/0001609151-25-000108.md) | [4.5 d](/filings/0001609151-25-000135.md) | [6.7 d](/filings/0001609151-26-000016.md) | [(0.2)](/filings/0001609151-26-000049.md) | [5.4 d](/filings/0001609151-26-000074.md) | [6.1 d](/filings/0001609151-25-000135.md) | [6.2 d](/filings/0001609151-26-000016.md) | [(5.7)](/filings/0001609151-26-000049.md) | [10.2 d](/filings/0001609151-26-000074.md) |
| Capital expenditure | $m | [0.7 d](/filings/0001609151-24-000149.md) | [0.2 d](/filings/0001609151-26-000016.md) | [0.5](/filings/0001609151-25-000058.md) | [0.7 d](/filings/0001609151-25-000108.md) | [0.5 d](/filings/0001609151-25-000135.md) | [0.4 d](/filings/0001609151-26-000016.md) | [0.4](/filings/0001609151-26-000049.md) | [0.5 d](/filings/0001609151-26-000074.md) | [0.3 d](/filings/0001609151-25-000135.md) | [1.1 d](/filings/0001609151-26-000016.md) | [0.5](/filings/0001609151-26-000049.md) | [0.6 d](/filings/0001609151-26-000074.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [65.1](/filings/0001609151-23-000031.md) | [66.0](/filings/0001609151-24-000050.md) | [66.8](/filings/0001609151-24-000093.md) | [68.2](/filings/0001609151-24-000149.md) | [70.5](/filings/0001609151-25-000058.md) | [71.3](/filings/0001609151-25-000108.md) | [72.0](/filings/0001609151-25-000135.md) | [73.8](/filings/0001609151-26-000049.md) | [75.8](/filings/0001609151-26-000074.md) | [77.3](/filings/0001609151-25-000135.md) | [78.6](/filings/0001609151-26-000049.md) | [79.6](/filings/0001609151-26-000074.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 79,999,119 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001609151-26-000074.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.